GAMCO Investors’s Meridian Bioscience Inc VIVO Stock Holding History

GAMCO Investors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-219,351	Closed	-$7.28M	–	920
2022 Q4	$7.28M	Sell	219,351 -1,955	-0.9%	-$63K	0.08%	260
2022 Q3	$6.98M	Sell	221,306 -32,094	-13%	-$1.04M	0.08%	256
2022 Q2	$7.71M	Hold	253,400	–	–	0.08%	255
2022 Q1	$6.58M	Sell	253,400 -2,600	-1%	-$61.8K	0.06%	302
2021 Q4	$5.22M	Buy	256,000 +10,000	+4%	+$192K	0.04%	344
2021 Q3	$4.73M	Buy	246,000 +40,000	+19%	+$797K	0.04%	364
2021 Q2	$4.57M	Sell	206,000 -2,000	-1%	-$42.4K	0.04%	376
2021 Q1	$5.46M	Sell	208,000 -3,000	-1%	-$71.3K	0.05%	337
2020 Q4	$3.94M	Hold	211,000	–	–	0.04%	366
2020 Q3	$3.58M	Sell	211,000 -7,000	-3%	-$136K	0.04%	369
2020 Q2	$5.08M	Sell	218,000 -16,000	-7%	-$232K	0.06%	307
2020 Q1	$1.97M	Sell	234,000 -10,000	-4%	-$84.2K	0.02%	434
2019 Q4	$2.38M	Buy	244,000 +24,000	+11%	+$225K	0.02%	470
2019 Q3	$2.09M	Buy	220,000 +56,000	+34%	+$590K	0.02%	484
2019 Q2	$1.95M	Hold	164,000	–	–	0.01%	506
2019 Q1	$2.89M	Hold	164,000	–	–	0.02%	438
2018 Q4	$2.85M	Hold	164,000	–	–	0.02%	412
2018 Q3	$2.44M	Sell	164,000 -8,000	-5%	-$124K	0.02%	460
2018 Q2	$2.73M	Sell	172,000 -3,000	-2%	-$44.7K	0.02%	445
2018 Q1	$2.48M	Hold	175,000	–	–	0.02%	444
2017 Q4	$2.45M	Hold	175,000	–	–	0.02%	461
2017 Q3	$2.5M	Hold	175,000	–	–	0.02%	461
2017 Q2	$2.76M	Hold	175,000	–	–	0.02%	446
2017 Q1	$2.42M	Buy	175,000 +35,000	+25%	+$489K	0.02%	463
2016 Q4	$2.48M	Hold	140,000	–	–	0.02%	464
2016 Q3	$2.7M	Hold	140,000	–	–	0.02%	451
2016 Q2	$2.73M	Hold	140,000	–	–	0.02%	463
2016 Q1	$2.88M	Hold	140,000	–	–	0.02%	448
2015 Q4	$2.87M	Hold	140,000	–	–	0.02%	445
2015 Q3	$2.39M	Buy	140,000 +1,000	+0.7%	+$18.3K	0.02%	484
2015 Q2	$2.59M	Hold	139,000	–	–	0.01%	489
2015 Q1	$2.65M	Hold	139,000	–	–	0.01%	497
2014 Q4	$2.29M	Sell	139,000 -1,000	-0.7%	-$17.2K	0.01%	517
2014 Q3	$2.48M	Buy	140,000 +10,000	+8%	+$196K	0.01%	512
2014 Q2	$2.68M	Buy	130,000 +38,000	+41%	+$781K	0.01%	505
2014 Q1	$2M	Buy	92,000 +2,000	+2%	+$45.8K	0.01%	518
2013 Q4	$2.39M	Hold	90,000	–	–	0.01%	490
2013 Q3	$2.13M	Hold	90,000	–	–	0.01%	501
2013 Q2	$1.94M	Buy	+90,000	New	+$1.94M	0.01%	493

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's VIVO Position: Q1 2023 in Review

GAMCO Investors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 219,351 shares — an estimated $7.28M sold.

GAMCO Investors first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $7.71M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

GAMCO Investors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
GAMCO Investors sold 219,351 Meridian Bioscience Inc shares in Q1 2023, an estimated $7.28M.
GAMCO Investors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
GAMCO Investors's Meridian Bioscience Inc position peaked at $7.71M in Q2 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.